Sophie Tartare‐Deckert

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index5.2kcitations191works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(48), Cellular Mechanics and Interactions(32), Cytokine Signaling Pathways and Interactions(25), Cell Adhesion Molecules Research(24), Advanced Breast Cancer Therapies(22)

Publications191 total

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization
Cell Reports·2025· 2 citedOpen Access
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway
2025Open Access
USP9X is a Mechanosensitive Deubiquitinase that Controls Tumor Cell Invasiveness and Drug Response Through YAP Stabilization
SSRN Electronic Journal·2025Open Access
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization
2024· 1 citedOpen Access
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway
2024Open Access
Supplementary Figure S3 from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
2023Open Access
Data from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 2 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure S1 from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
2023Open Access
Data from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
2023Open Access
Supplementary Data from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
2023Open Access
Supplementary Figure 5 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Methods and Figure Legends from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 4 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 4 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 2 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 5 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 3 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure S1 from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
2023Open Access
Supplementary Methods and Figure Legends from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Marcel Deckert(19), Robert Ballotti(13), Stéphane Rocchi(13), Emmanuel Van Obberghen(8), Corine Bertolotto(8), Mélanie Tichet(8), Guillaume Robert(7), Nina Fenouille(7), Aude Mallavialle(7), Mickaël Ohanna(7), Dominique Sawka‐Verhelle(7), Cédric Gaggioli(7), Alexandre Puissant(6), Patrick Auberger(6), Patricia Abbe(6), Bernard Mari(5), Philippe Bahadoran(5), Jean‐Christophe Marine(5), Carine Chavey(4), J.‐P. Lacour(4)